Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Intelligent Bio Solutions ( (INBS) ) just unveiled an update.
On July 23, 2025, Intelligent Bio Solutions Inc. announced the successful collection of new data that enhances the security and performance of its Intelligent Fingerprinting Drug Screening System, bolstering its FDA 510(k) submission. The company completed rigorous testing to validate the system’s resilience and accuracy, positioning it strongly for FDA clearance. This advancement supports the company’s goal to enter the U.S. market in 2025 and expand its international operations, addressing the growing demand for workplace safety solutions.
Spark’s Take on INBS Stock
According to Spark, TipRanks’ AI Analyst, INBS is a Neutral.
INBS displays strong technical momentum and benefits from positive corporate events, supporting its international growth strategy. However, challenges with profitability and valuation due to negative earnings temper the overall outlook.
To see Spark’s full report on INBS stock, click here.
More about Intelligent Bio Solutions
Intelligent Bio Solutions Inc. is a medical technology company that provides intelligent, rapid, non-invasive testing solutions. The company focuses on the Intelligent Fingerprinting Drug Screening System, which uses fingerprint sweat analysis to detect drugs commonly found in workplaces, such as opiates, cocaine, methamphetamine, and cannabis. The company serves safety-critical industries and operates in 24 countries with 18 distribution partners.
Average Trading Volume: 161,762
Technical Sentiment Signal: Hold
Current Market Cap: $15.55M
Learn more about INBS stock on TipRanks’ Stock Analysis page.